Delivery Order SPE2DB20D2104-SPE2DB22FR70U

Award Date 2/1/22
Potential Completion Date 2/2/22
Potential Value $1.1K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Trulicity 0.75 mg/0.5 ml pen 0.5 ml, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $3,462.29, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
This federal contract award is for the delivery of Trulicity 0.75 mg/0.5 ml pen 0.5 ml, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $2,401.53, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
This federal contract award is for the delivery of Trulicity 1.5 mg/0.5 ml pen 0.5 ml, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., for a ceiling value of $3,098.10. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026....
This federal contract award is for the delivery of Trulicity 1.5 mg/0.5 ml pen 0.5 ml to the Defense Logistics Agency (DLA). The contract, valued at $2,698.08, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as the primary vehicle for Cencora, Inc. to provide...
This federal contract award is for the delivery of Trulicity 0.75 mg/0.5 ml pen 0.5 ml, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., and has a ceiling value of $7,798.98. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December...
This federal contract award is for the delivery of Trulicity 1.5 mg/0.5 ml pens to the Defense Logistics Agency (DLA). The $1,094.10 contract was awarded to Amerisourcebergen Drug Corp, a pharmaceutical distribution company that serves as a prime contractor for various federal healthcare programs. The contract is a delivery order under an Indefinite Delivery Contract (IDC) between Amerisourcebergen's parent company, Cencora, Inc., and the DLA Troop Support Medical, valued at up to...
This federal contract award is for the delivery of Trulicity 0.75 mg/0.5 ml pen 0.5 ml to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a pharmaceutical distribution company, for a ceiling value of $3,720.96 and has an ultimate completion date of September 19, 2023. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This...
This federal contract award is for the delivery of Trulicity 0.75 mg/0.5 ml pens to the Defense Logistics Agency (DLA). The contract, valued at $1,836.86, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as the primary vehicle for...
This federal contract award is for the delivery of Trulicity 1.5 mg/0.5 ml pens to the Defense Logistics Agency (DLA). The contract, valued at $2,612.52, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as a primary...
This federal contract award is for the delivery of Trulicity 3 mg/0.5 ml pens (0.5 ml) to the Defense Logistics Agency (DLA). The contract, with a ceiling value of $2,612.52, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB22FR70U
    Delivery Order

This federal contract award is for the delivery of Trulicity 0.75 mg/0.5 ml pen 0.5 ml, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,105.67, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc.

The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as a primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 11:37 AM